Individualizing Corticosteroid Use in Pneumonia
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05334316
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Pneumonia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dexamethasone — DRUGAdministered intravenously or orally based on daily CRP values and CRP corticosteroid dosing algorithm
Study Details
In this study, researchers propose a unique (individualized) approach to steroid treatment seeking to give the right dose of steroid to the right patient and at the right time. This study seeks to compare usual care to an individualized steroid dosing strategy by testing a marker of inflammation in the blood called C- reactive protein (CRP). The overall goal is to reduce an individual's exposure to steroids and the risk of potential side effects thereby increasing the potential benefit of using steroids to control inflammation in pneumonia.
Key Dates
- Start date
- Nov 6, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: Usual Care GroupUsual care as determined by the patient's primary team. Initiation and daily dosing of corticosteroid treatment will be based on clinicians' preference and clinicians.
- Experimental: Individualized dosing strategyBiomarker guided corticosteroid use. Initiation of corticosteroid will be recommended based on the an individual treatment rule (ITR) and subsequent dosing of corticosteroid will be recommended based on daily CRP values till CRP \<50 mg/L.
Primary Outcome Measure
Adherence to individual treatment rule and CRP-guided corticosteroid treatment [ Time Frame: First 5 days of hospitalization or until hospital discharge (whichever is sooner) ]
Central Contacts
- Yewande Odeyemi, M.B.B.S.507-284-2494
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | Amy L Amsbaugh |
Find similar trials in Rochester, MN
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-ConsultsNot Yet Recruiting · Seattle Institute for Biomedical and Clinical Research · Boise, Idaho
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Study of Lung Proteins in Patients With PneumoniaRecruiting · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland